Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: Involvement of the GSK-3β/Nrf2 signaling pathway

Free Radical Research

Volumn 47, Issue 1, 2013, Pages 55-63

  Zou, Y ^a   Hong, B ^a   Fan, L ^a   Zhou, L ^a   Liu, Y ^a   Wu, Q ^a   Zhang, X ^a   Dong, M ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid beta; Antioxidant; Heme oxygenase 1; Oxygen species; Reactive

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1; LITHIUM CHLORIDE; PUERARIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL SURVIVAL; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HEME OXYGENASE-1; HIPPOCAMPUS; ISOFLAVONES; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; UP-REGULATION;

PUERARIA MONTANA VAR. LOBATA; RATTUS;

EID: 84870798936     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.742518     Document Type: Article

References (51)

1. Ardiles AO, Tapia-Rojas CC, Mandal M, Alexandre F, Kirkwood A, Inestrosa NC, Palacios AG. Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer ' s disease. Proc Natl Acad Sci USA 2012; 109: 13835-13840.
2. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer ' s disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry 2007; 78: 30-35.
3. May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, et al. Robust central reduction of amyloid-Βin humans with an orally available, non-peptidic Β-secretase inhibitor. J Neurosci 2011; 31: 16507-16516.
4. Cuevas E, Lantz SM, Tob ?n-Velasco JC, Newport GD, Wu Q, Virmani A, et al. On the in vivo early toxic properties of A-beta 25-35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression. Neurotoxicol Teratol 2011; 33: 288-296.
5. Sultana R, Mecocci P, Mangialasche F, Cecchetti R, Baglioni M, Butterfield DA. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer ' s disease: insights into the role of oxidative stress in Alzheimer ' s disease and initial investigations into a potential biomarker for this dementing disorder. J Alzheimers Dis 2011; 24: 77-84.
6. Michel TM, Gsell W, K ?sbauer L, Tatschner T, Sheldrick AJ, Neuner I, et al. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer ' s disease: a human postmortem study. J Alzheimers Dis 2010; 19: 1295-301.
7. Melo JB, Sousa C, Garo P, Oliveira CR, Agostinho P. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. Eur J Neurosci 2009; 29: 455-464.
8. Ahlbom E, Gogvadze V, Chen M, Celsi G, Ceccatelli S. Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stressinduced cell death. Proc Natl Acad Sci USA 2000; 97: 14726-14730.
9. Khan A, Vaibhav K, Javed H, Moshahid Khan M, Tabassum R, Ahmed ME, et al. Attenuation of A Β-induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress. Mol Cell Biochem 2012; 369: 55-65.
10. Kumar A, Ahmad I, Shukla S, Singh BK, Patel DK, Pandey HP, et al. Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 2010; 44: 950-965.
11. Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson ' s disease: critical role for the astrocyte. Proc Natl Acad Sci USA 2009; 106: 2933-2938.
12. Rojo AI, Rada P, Egea J, Rosa AO, L ?pez MG, Cuadrado A. Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci 2008; 39: 125-132.
13. Narasimhan M, Mahimainathan L, Rathinam ML, Riar AK, Henderson GI. Overexpression of Nrf2 protects cerebral cortical neurons from ethanol-induced apoptotic death. Mol Pharmacol 2011; 80: 988-999.
14. Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 2006; 281: 14841-14851.
15. Espada S, Rojo AI, Salinas M, Cuadrado A. The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection. J Neurochem 2009; 110: 1107-1119.
16. Chakrabarti S, Munshi S, Banerjee K, Thakurta IG, Sinha M, Bagh MB. Mitochondrial dysfunction during brain aging: role of oxidative stress and modulation by antioxidant supplementation. Aging Dis 2011; 2: 242-256.
17. McManus MJ, Murphy MP, Franklin JL. The mitochondriatargeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer' s disease. J Neurosci 2 011; 3 1: 1 5703-1 5715.
18. Djeridane A, YousfiM, Brunel JM, Stocker P. Isolation and characterization of a new steroid derivative as a powerful antioxidant from Cleome arabica in screening the in vitro antioxidant capacity of 18 Algerian medicinal plants. Food Chem Toxicol 2010; 48: 2599-2606.
19. Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo K, Kim JS. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic Biol Med 2012; 53: 357-365.
20. Yu Z, Li W. Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Lett 2006; 238: 53-60.
21. Zhu LH, Wang L, Wang D, Jiang H, Tang QZ, Yan L, et al. Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. Free Radic Biol Med 2010; 48: 471-482.
22. Li J, Wang G, Liu J, Zhou L, Dong M, Wang R, et al. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. Eur J Pharmacol 2010; 649: 195-201.
23. Lee SJ, Campomanes CR, Sikat PT, Greenfield A T, A llen P B, McEwen BS. Estrogen induces phosphorylation of cyclic AMP response element binding (pCREB) in primary hippocampal cells in a time-dependent manner. Neuroscience 2004; 124: 549-560.
24. Pirondi S, Giuliani A, Del Vecchio G, Giardino L, H ?kfelt T, Calz?L. The galanin receptor 2/3 agonist Gal2-11 protects the SN56 cells against beta-amyloid 25-35 toxicity. J Neurosci Res 2010; 88: 1064-1073.
25. Li CC, Xing GH, Dong MX, Zhou L, Li JM, Wang G, et al. Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12 cells via JNK signaling and Modulation of Bcl-2 family proteins1. Eur J Pharmacol 2010; 635: 96-102.
26. Xu X, Zheng X. Potential involvement of calcium and nitric oxide in protective effects of puerarin on oxygen-glucose deprivation in cultured hippocampal neurons. J Ethnopharmacol 2007; 113: 421-426.
27. Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M, Butterfield DA. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 2012; 52: 2292-2301.
28. Levonen AL, Inkala M, Heikura T, Jauhiainen S, Jyrkk ?nen HK, Kansanen E, et al. Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioscler Thromb Vasc Biol 2007; 27: 741-747.
29. Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 7789-7793.
30. Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH. Amyloid-independent mechanisms in Alzheimer ' s disease pathogenesis. J Neurosci 2010; 30: 14946-54.
31. Eckman EA, Eckman CB. Abeta-degrading enzymes: modulators of Alzheimer ' s disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 2005; 33: 1101-1105.
32. Isobe C, Abe T, Terayama Y. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2 '-deoxyguanosine in the CSF of patients with Alzheimer ' s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. J Neurol 2010; 257: 399-404.
33. Tayler H, Fraser T, Miners JS, Kehoe PG, Love S. Oxidative balance in Alzheimer ' s disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid. J Alzheimers Dis 2010; 22: 1363-1373.
34. Wan L, Nie G, Zhang J, Luo Y, Zhang P, Zhang Z, Zhao B. β-Amyloid peptide increases levels of iron content and oxidative stress in human cell. and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 2011; 50: 122-129.
35. Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, Wang Z. Neuroprotective effects of salidroside against beta-amyloidinduced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int 2010; 57: 547-555.
36. Bergstr ?m P, Andersson HC, Gao Y, Karlsson JO, Nodin C, Anderson MF, et al. Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage. Neuropharmacology 2011; 60: 343-353.
37. Choudhry F, Howlett DR, Richardson JC, Francis PT, Williams RJ. Pro-oxidant diet enhances-/-secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiol Aging 2012; 33: 960-968.
38. Doggui S, Sahni JK, Arseneault M, Dao L, Ramassamy C. Neuronal uptake and neuroprotective effect of curcuminloaded PLGA nanoparticles on the human SK-N-SH cell line. J Alzheimers Dis 2012; 30: 377-392.
39. Jain AK, Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 2007; 282: 16502-16510.
40. Lee HG, Li MH, Joung EJ, Na HK, Cha YN, Surh YJ. Nrf2-Mediated heme oxygenase-1 upregulation as adaptive survival response to glucose deprivation-induced apoptosis in HepG2 cells. Antioxid Redox Signal 2010; 13: 1639-1648.
41. Mateo I, S ?nchez-Juan P, Rodr ?guez-Rodr ?guez E, Infante J, V ?quez-Higuera JL, Garc?-Gorostiaga I, et al. Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer ' s disease risk. Dement Geriatr Cogn Disord 2008; 26: 339-342.
42. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 2006; 27: 252-261.
43. Song W, Su H, Song S, Paudel HK, Schipper HM. Overexpression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J Cell Physiol 2006; 206: 655-663.
44. Rojo AI, Sagarra MR, Cuadrado A. GSK-3beta downregulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 2008; 105: 192-202.
45. Leroy K, Yilmaz Z, Brion JP. Increased level of active GSK-3beta in Alzheimer ' s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 2007; 33: 43-55.
46. Papasozomenos SCh, Shanavas A. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer ' s disease. Proc Natl Acad Sci USA 2002; 99: 1140-1145.
47. Garza JC, Guo M, Zhang W, Lu XY. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3-/-catenin signaling. Mol Psychiatry 2012; 17: 790-808.
48. Boku S, Nakagawa S, Masuda T, Nishikawa H, Kato A, Kitaichi Y, et al. Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3beta and beta-catenin/TCF pathway. Neuropsychopharmacology 2009; 34: 805-815.
49. Jain AK, Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 2007; 282: 16502-16510.
50. Sch ?fer M, Goodenough S, Moosmann B, Behl C. Inhibition of glycogen synthase kinase 3 beta is involved in the resistance to oxidative stress in neuronal HT22 cells. Brain Res 2004; 1005: 84-89.
51. Tan WF, Cao XZ, Wang JK, Lv HW, Wu BY, Ma H. Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats. Clin Exp Pharmacol Physiol 2010; 37: 1010-1015.